Nanomedicine in the Treatment and Management of Alzheimer's Disease

Discover the groundbreaking insights in "Nanomedicine in the Treatment and Management of Alzheimer's Disease," authored by experts in the field and published by Taylor & Francis Ltd in 2025. This comprehensive hardback edition spans 368 pages, delving into innovative drug delivery methods utilizing nanoparticles for neuroprotective therapies. The book explores a variety of approaches, including enzymes, monoclonal antibodies, neurotrophic factors, pharmaceutical drugs, and nucleic acid-based treatments, all aimed at effectively managing Alzheimer's disease. Ideal for researchers, healthcare professionals, and anyone interested in the latest advancements in nanomedicine, this essential resource offers a thorough understanding of how these cutting-edge technologies can revolutionize the treatment landscape for Alzheimer's. Enhance your knowledge and stay ahead in the field with this pivotal work.